Showing results (291-300 of 604) with videos related to

Sort By:
Pageof 61
Plos One|February 9, 2010
Only slight impact of predicted replicative capacity for therapy response predictionHendrik Weisser, André Altmann, Saleta Sierra, et al.
Journal of Molecular Biology|May 4, 2019
Near-Neighbor Interactions in the NS3-4A Protease of HCV Impact Replicative Fitness of Drug-Resistant Viral VariantsNadezhda T Doncheva, Francisco S Domingues, David R McGivern, et al.
Journal of Hepatology|November 22, 2008
Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis CUlrike Mihm, Oliver Ackermann, Christoph Welsch, et al.
Scientific Reports|November 28, 2015
Assembly of the MHC I peptide-loading complex determined by a conserved ionic lock-switchAndreas Blees, Katrin Reichel, Simon Trowitzsch, et al.
Acta Neurochirurgica|November 7, 2016
Contrast-enhanced shunt series ("shuntography") compare favorably to other shunt imaging modalities in detecting shunt occlusionKajetan L von Eckardstein, Kai Kallenberg, Marios-Nikos Psychogios, et al.
Neurosurgery|June 15, 2026
Clinical Relevance of Early Cranial Computed Tomography-Imaging After Elective Brain Tumor Surgery in Children and AdolescentsEmilia Lucia Schulz, Hans Christoph Bock, Charlotte Flüh, et al.
Acta Neurochirurgica|September 4, 2019
miRNA-26a expression influences the therapy response to carmustine wafer implantation in patients with glioblastoma multiformeChristoph Sippl, Ralf Ketter, Luisa Braun, et al.
Scientific Reports|February 2, 2024
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2Markus Hoffmann, Lina-Liv Willruth, Alexander Dietrich, et al.
Biorxiv : the Preprint Server for Biology|December 11, 2023
Blood transcriptomics analysis offers insights into variant-specific immune response to SARS-CoV-2Markus Hoffmann, Lina-Liv Willruth, Alexander Dietrich, et al.
Antiviral Therapy|May 17, 2007
Improved prediction of response to antiretroviral combination therapy using the genetic barrier to drug resistanceAndre Altmann, Niko Beerenwinkel, Tobias Sing, et al.
Pageof 61